Urology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Endoscopes, Dialysis Devices, Laser & Lithotripsy Devices, Endovision & Imaging Devices, Catheters, Urodynamic Systems, Stents, Biopsy Devices, Others) By Procedure Type (Minimally Invasive Surgery Devices and Robotic Surgery) By Application (Kidney Diseases, Urological Cancer & BPH, Pelvic Organ Prolapse, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Dialysis Centers, Home Care Settings), By Region and Competition, 2020-2030F

Market Overview

The Global Urology Devices Market, valued at USD 36.29 Billion in 2024, is projected to experience a CAGR of 7.20% to reach USD 55.08 Billion by 2030. Urology devices encompass a broad range of medical instruments and equipment designed for the diagnosis, treatment, and management of conditions affecting the urinary tract in both genders, and the male reproductive system. These devices include endoscopes, catheters, dialysis machines, lithotripsy systems, and surgical instruments utilized across various urological procedures. The market's expansion is fundamentally driven by the escalating global prevalence of urological disorders, such as benign prostatic hyperplasia, kidney stones, and urinary incontinence, alongside the increasing geriatric population more susceptible to these conditions. The continuous development of minimally invasive surgical techniques also contributes significantly to demand.

A critical challenge impeding market expansion is the high cost associated with advanced urology devices and procedures, which can limit access, particularly in developing regions with constrained healthcare budgets and limited reimbursement policies. Nevertheless, the market continues its trajectory, supported by the healthcare infrastructure. According to the American Urological Association, in 2023, there were 14,176 practicing urologists in the U. S. , reflecting the substantial professional base driving device utilization.

Key Market Drivers

The global urology devices market is significantly influenced by the rising prevalence of urological diseases and cancers, which directly translates into a greater need for diagnostic tools, treatment systems, and long-term management solutions. Conditions such as bladder cancer, kidney stones, and benign prostatic hyperplasia necessitate a broad spectrum of interventions, from early detection to complex surgical procedures. For instance, according to the International Agency for Research on Cancer, in August 2023, GLOBOCAN 2022 data estimated 614,298 new bladder cancer cases worldwide in 2022, highlighting the substantial and growing patient population requiring specialized urological care. Concurrently, the aging global population serves as another fundamental driver, as older individuals are inherently more susceptible to developing various urological conditions. Age-related physiological changes increase the incidence of issues like urinary incontinence, prostatic enlargement, and kidney dysfunction, thereby accelerating the demand for associated medical devices. According to the World Health Organization, in February 2025, the number of people aged 60 and older worldwide is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030, creating an expanding demographic pool consistently requiring urological diagnostic and therapeutic solutions.

These demographic and epidemiological trends underscore a sustained and increasing need for urology devices across the care continuum. The market responds to this demand through the development of advanced instrumentation and comprehensive treatment pathways, ensuring that healthcare providers are equipped to manage the growing burden of urological health challenges globally. Reflecting the expansive professional network supporting this medical field, according to the American Urological Association Annual Report, in 2023, the association had more than 25,000 members representing 138 countries globally.

Download Free Sample Report

Key Market Challenges

A critical challenge impeding the growth of the Global Urology Devices Market is the high cost associated with advanced urology devices and procedures. This financial barrier directly hampers market expansion by severely limiting access, particularly in developing regions with constrained healthcare budgets and insufficient reimbursement policies. Elevated costs often compel healthcare systems and individuals to prioritize basic or emergency care, deferring investment in and adoption of newer, more effective diagnostic and therapeutic technologies.

This constraint is substantial, evidenced by the economic burden of prevalent urological conditions. According to the European Association of Urology, in 2023, the cost of continence care in Europe alone exceeded 40 billion Euros, with a considerable portion related to patient productivity loss and continence products. Such significant financial outflows towards managing fundamental urological conditions in economically key regions demonstrate how high costs divert resources, consequently diminishing the budget available for advanced urology devices and slowing overall market penetration.

Key Market Trends

The expansion of minimally invasive and robotic surgical platforms significantly drives the global urology devices market by offering enhanced precision and improved patient outcomes. These advanced technologies facilitate reduced trauma, shorter hospital stays, and faster recovery. The European Association of Urology's 2024 guidelines noted increasing Minimally Invasive Surgery (MIS) use in paediatric urology, reflecting broader clinical adoption. In March 2024, Intuitive received U. S. Food and Drug Administration clearance for its fifth-generation robotic system, da Vinci 5, initiating a phased launch for enhanced surgical capabilities. This ongoing innovation fuels demand for specialized instruments and integrated robotic systems, profoundly influencing urological surgical practice.

The integration of artificial intelligence in diagnostics and treatment is transforming urological care by enhancing accuracy and efficiency. AI applications include advanced image analysis, predictive analytics, and personalized treatment planning. According to the American Urological Association's 2024 Annual Census, 14% of practicing urologists reported using AI for generating discharge instructions, demonstrating practical adoption within clinical workflows. In October 2023, Philips collaborated with Quibim to introduce AI-based imaging and reporting solutions for magnetic resonance prostate examinations, aiming to improve early detection and diagnostic accuracy. These advancements foster informed clinical decisions and operational improvements, expanding the market for AI-powered software and integrated diagnostic systems in urology.

Segmental Insights

The Endoscopes segment is experiencing rapid growth within the Global Urology Devices Market, primarily driven by continuous technological advancements and a growing preference for minimally invasive surgical procedures. Innovations in imaging, material science, and design have led to the development of highly effective endoscopes that offer superior visualization and maneuverability, thereby enhancing diagnostic accuracy and therapeutic outcomes. This aligns with the increasing patient and physician demand for procedures that offer quicker recovery times, reduced complications, and shorter hospital stays compared to traditional open surgeries. Furthermore, the rising global prevalence of various urological disorders, such as urolithiasis, prostate cancer, and bladder conditions, significantly boosts the demand for endoscopic interventions for both diagnosis and treatment.

Regional Insights

North America leads the global urology devices market, primarily driven by its well-established healthcare infrastructure and substantial healthcare investments. The region benefits from a significant presence of key market players who possess extensive expertise and robust distribution networks. Furthermore, North America demonstrates rapid adoption of technological advancements, including minimally invasive and robotic-assisted surgical platforms, supported by a strong research and development environment. Favorable reimbursement policies and consistent regulatory support from bodies such as the U. S. Food and Drug Administration (FDA) also foster market growth. This is further amplified by the high prevalence of various urological conditions, such as kidney diseases and prostate cancer, necessitating advanced diagnostic and treatment solutions.

Recent Developments

• In September 2025, Olympus Corporation announced an exclusive global distribution agreement with MacroLux Medical Technology Co., Ltd. for single-use urology products. This collaboration expands Olympus's urology portfolio to include multiple single-use cystoscopes, ureteroscopes, and suction access sheaths. These devices are crucial for accessing and visualizing the bladder and urinary tract to diagnose and treat conditions such as kidney stones. The partnership reflects a strategic move to integrate innovative single-use technology, aiming to enhance the landscape of urological care for customers and patients globally.

• In May 2024, Teleflex Incorporated introduced the UroLift 2 System with Advanced Tissue Control (ATC), marking a new product launch in the global urology devices market. This system, which recently received FDA clearance, aims to provide physicians with increased confidence, improved control over obstructive tissue, and enhanced targeting accuracy. The UroLift 2 ATC System features tissue control wings and laser-etched needle markers, designed for more precise tissue manipulation and implant delivery. This advancement offers an improved minimally invasive treatment option for benign prostatic hyperplasia (BPH).

• In April 2024, Olympus received FDA clearance for its RenaFlex single-use flexible ureteroscope system, significantly expanding its urology portfolio. This innovative device facilitates enhanced access and visualization within the urinary tract for the diagnosis and treatment of various urinary conditions, including kidney stones. Designed for use with endotherapeutic accessories, the RenaFlex system enables both diagnostic and therapeutic procedures through transurethral or percutaneous routes, supporting high-quality patient care in the global urology devices market. The system was made available through a limited market launch in 2024.

• In late 2024, AngioDynamics received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NanoKnife System for prostate tissue ablation. Further supporting this breakthrough, in July 2025, *European Urology* published results from the PRESERVE study, which evaluated the NanoKnife System for treating intermediate-risk prostate cancer. The study demonstrated favorable outcomes in both oncologic effectiveness and the preservation of patient quality of life, particularly regarding urinary and sexual function, positioning the NanoKnife System as a significant advancement in the global urology devices market.

Key Market Players

• Boston Scientific Corporation
• Fresenius Medical Care AG & Co. KgaA
• Baxter International Inc.
• Becton, Dickinson, and Company
• Olympus Corporation
• B. Braun Melsungen AG
• Medtronic Plc
• Stryker Corporation
• Teleflex Incorporated
• Cook Medical, Inc.

Report Scope:

In this report, the Global Urology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Urology Devices Market, By Type:

o   Endoscopes

o   Dialysis Devices

o   Laser & Lithotripsy Devices

o   Endovision & Imaging Devices

o   Catheters

o   Urodynamic Systems

o   Stents

o   Biopsy Devices

o   Others

• Urology Devices Market, By Procedure Type:

o   Minimally Invasive Surgery Devices

o   Robotic Surgery

• Urology Devices Market, By Application:

o   Kidney Diseases

o   Urological Cancer & BPH

o   Pelvic Organ Prolapse

o   Others

• Urology Devices Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Dialysis Centers

o   Home Care Settings

• Urology Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urology Devices Market.

Available Customizations:

Global Urology Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Urology Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]